Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) > Polycyclo ring system having the six-membered hetero ring as one of the cyclos (e.g., maytansinoids, etc.) > Bicyclo ring system having the six-membered hetero ring as one of the cyclos (e.g., 1,4-benzoxazines, etc.) > Patents

Resources

Home

Browse by:

Browse by Category: Main > Health & Medicine

Class Information
Number: 514/230.5
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) > Polycyclo ring system having the six-membered hetero ring as one of the cyclos (e.g., maytansinoids, etc.) > Bicyclo ring system having the six-membered hetero ring as one of the cyclos (e.g., 1,4-benzoxazines, etc.)
Description: Subject matter in which the six-membered hetero ring is one of the cyclos of a bicyclo ring system.

Patents under this class:

1 2 3 4 5 6 7 8 9 10 11 12

Patent Number	Title Of Patent	Date Issued
7618977	Method of treating dermatitis comprising administering a chymase inhibitor	Nov. 17, 2009
7618960	Morpholine type cinnamide compound	Nov. 17, 2009
7615551	Salicylate and gentisate salts of a piperazine compound	Nov. 10, 2009
7601712	Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient	Oct. 13, 2009
7601713	Kinase inhibitors and their uses	Oct. 13, 2009
7598253	Reverse-turn mimetics and methods relating thereto	Oct. 6, 2009
7595310	Glucuronate salt of a piperazine compound	Sep. 29, 2009
7595063	Compressed tablet formulation	Sep. 29, 2009
7595343	Inhibitors of histone deacetylase	Sep. 29, 2009
7592335	Oxazolidinone derivatives as antimicrobials	Sep. 22, 2009
7579345	Muscarinic acetylcholine receptor antagonists	Aug. 25, 2009
7579344	Pyrimidine derivatives possessing cell-cycle inhibitors activity	Aug. 25, 2009
7569564	Cyclothiocarbamate derivatives as progesterone receptor modulators	Aug. 4, 2009
7569565	Pharmaceutical composition for the prevention or treatment of cerebral oedemas	Aug. 4, 2009
7569574	Purine derivatives, the preparation thereof and their use as pharmaceutical compositions	Aug. 4, 2009
7566707	Imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions	Jul. 28, 2009
7560450	Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions	Jul. 14, 2009
7560466	Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds	Jul. 14, 2009
7557122	Pyrrolopyridine compounds, method of making them and uses thereof	Jul. 7, 2009
7550460	2,4-pyrimidinediamine compounds and their uses	Jun. 23, 2009
7550459	Tetrahydroquinoline analogues as muscarinic agonists	Jun. 23, 2009
7541356	Compounds for use in weight loss and appetite suppression in humans	Jun. 2, 2009
7538108	Prodrugs of 2,4-pyrimidinediamine compounds and their uses	May. 26, 2009
7534789	Enantiomeric pure .beta. agonists, manufacturing and use as a medicament thereof	May. 19, 2009
7528106	Compositions and methods for treatment of neovascular diseases	May. 5, 2009
7524843	Fab I inhibitors	Apr. 28, 2009
7514429	Benzoxazinone-derived compounds, their preparation and use as medicaments	Apr. 7, 2009
7511035	Antibacterial agents	Mar. 31, 2009
7511037	N-[[4-fluoro-2-(5-methy-1H-1,2,4-triazol-1-yl)phenyl]methyl]-4-,6,7,9-tetr- ahydro-3-hydroxy-9,9-dimethyl-4-oxo-pyrimido[2,1-c][1,4]oxazine-2-carboxam- ide as an HIV integrase inhibitor	Mar. 31, 2009
7507731	Compounds for use in weight loss and appetite suppression in humans	Mar. 24, 2009
7504395	Treatment for attention-deficit hyperactivity disorder	Mar. 17, 2009
7494984	Substituted imidazo[1,2-a]pyrimidines as HIV viral DNA integrase inhibitors	Feb. 24, 2009
7491714	Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents	Feb. 17, 2009
7491719	Enantiomerically pure beta agonists, process for the manufacture thereof, and use thereof as medicaments	Feb. 17, 2009
7488725	Pyrrolidinyl beta-amino amide-based inhibitors of dipeptidyl peptidase IV and methods	Feb. 10, 2009
7470684	Spiropiperidine derivatives as NK3 antagonists	Dec. 30, 2008
7449458	Prodrugs of 2,4-pyrimidinediamine compounds and their uses	Nov. 11, 2008
7442696	Mineralocorticoid receptor modulator compounds, processes for their preparation, and their uses	Oct. 28, 2008
7435744	Piperidine derivatives as NMDA receptor antagonists	Oct. 14, 2008
7432259	Spiro-piperidine derivatives	Oct. 7, 2008
7432258	Morpholinyl and pyrrolidinyl analogs	Oct. 7, 2008
7429583	Betamimetics for the treatment of respiratory complaints	Sep. 30, 2008
7427616	Condensed pyridines and pyrimidines with tie2 (TEK) activity	Sep. 23, 2008
7427617	Morpoline-bridged indazole derivatives	Sep. 23, 2008
7423035	Substituted cycloalkyl derivatives, process for the manufacture thereof and use thereof as medicament	Sep. 9, 2008
7423036	Long-acting betamimetics for the treatment of respiratory complaints	Sep. 9, 2008
7419967	Sulfonamide inhibitors of aspartyl protease	Sep. 2, 2008
7417041	Imidazopyrimidines as transforming growth factor (TGF) inhibitors	Aug. 26, 2008
7414052	Phenylaminopropanol derivatives and methods of their use	Aug. 19, 2008
7407954	Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity	Aug. 5, 2008